Oncotelic Therapeutics Inc (OTLC): Uh oh, CA4P failed in phase II, phase II...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 09/04/2017 3:14:53 PM

Monday, September 04, 2017 3:14:53 PM

Uh oh, CA4P failed in phase II, phase III to be cancelled, MATN/OXGN to go out of business?

https://seekingalpha.com/news/3289840-mateons-ca4p-fails-match-response-rate-placebo-regimen-treatment-resistant-ovarian-cancer

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:00:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 01:00:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 02:30:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:00:34 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/13/2023 01:25:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 01:15:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 01:25:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!